The journal Drug Safety has retracted a post-marketing safety study of Covaxin, India’s first homegrown covid-19 vaccine,1 which has been causing heated debate across India and the world.2 The ...

Journal retracts study on Covaxin safety, sparking controversy and defamation case, raising concerns about scientific ...

The study titled “Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: findings from a ...

The controversial study on the Covaxin vaccine, published by a team of researchers at the Banaras Hindu University (BHU) has ...

Bharat Biotech has taken legal action against 11 BHU researchers and the journal Drug Safety over a study on Covaxin's side ...

An international peer-reviewed journal has decided to retract a paper by a team of Indian researchers that had claimed that “serious adverse events may occur in one per cent” of recipients of Covaxin, ...

In the letter they added, ‘Like most research studies, this study has various limitations which the authors acknowledge within the paper. In the case of COVID-19 vaccines, which were universally ...

HYDERABAD: Bharat Biotech, developer of India's first indigenous Covid-19 vaccine Covaxin, has taken 11 Benaras Hindu University (BHU) researchers along with international medical journal Drug ...

The questions of drugs, real and spurious, has come up in the healthcare sector this week, with reports of drugs not meeting ...

The New India: The Unmaking of the World’s Largest Democracy. By Rahul Bhatia. Abacus; 352 pages; £25. To be published in America by PublicAffairs in November; $32 It is not uncommon for poor ...

It's not a thaw yet, but there are certainly signs of some warming in the India-China relationship. Of late, there has been an uptick in dialogue to resolve outstanding issues along two friction ...